 Christopher Lowry
Concepts (653)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin | 60 | 2022 | 292 | 10.550 |
Why?
| | Raphe Nuclei | 41 | 2019 | 110 | 9.630 |
Why?
| | Tryptophan Hydroxylase | 34 | 2022 | 52 | 6.370 |
Why?
| | Anxiety | 45 | 2023 | 843 | 4.970 |
Why?
| | Stress, Psychological | 35 | 2021 | 944 | 4.740 |
Why?
| | Serotonergic Neurons | 16 | 2022 | 24 | 4.740 |
Why?
| | Mycobacterium | 12 | 2023 | 103 | 4.710 |
Why?
| | Mycobacteriaceae | 11 | 2023 | 21 | 4.320 |
Why?
| | Dorsal Raphe Nucleus | 14 | 2023 | 27 | 3.630 |
Why?
| | Neurons | 43 | 2022 | 1277 | 3.620 |
Why?
| | Proto-Oncogene Proteins c-fos | 23 | 2019 | 165 | 3.550 |
Why?
| | Amygdala | 21 | 2022 | 171 | 3.490 |
Why?
| | Fear | 16 | 2023 | 292 | 3.470 |
Why?
| | Corticotropin-Releasing Hormone | 18 | 2018 | 67 | 3.450 |
Why?
| | Rats | 79 | 2022 | 4913 | 3.260 |
Why?
| | Behavior, Animal | 25 | 2023 | 459 | 3.120 |
Why?
| | Corticosterone | 24 | 2021 | 211 | 3.060 |
Why?
| | Gastrointestinal Microbiome | 15 | 2023 | 502 | 2.980 |
Why?
| | Microbiota | 15 | 2023 | 648 | 2.930 |
Why?
| | Animals | 165 | 2023 | 31565 | 2.630 |
Why?
| | Stress Disorders, Post-Traumatic | 14 | 2023 | 757 | 2.360 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 32 | 2.260 |
Why?
| | Rats, Wistar | 34 | 2020 | 368 | 2.200 |
Why?
| | Anti-Inflammatory Agents | 9 | 2023 | 445 | 2.100 |
Why?
| | Hyperthermia, Induced | 6 | 2023 | 66 | 2.090 |
Why?
| | Inflammation | 26 | 2023 | 2464 | 2.050 |
Why?
| | Antidepressive Agents | 9 | 2023 | 195 | 1.990 |
Why?
| | Extinction, Psychological | 4 | 2023 | 78 | 1.980 |
Why?
| | Depressive Disorder, Major | 9 | 2023 | 301 | 1.940 |
Why?
| | Pituitary-Adrenal System | 11 | 2019 | 130 | 1.850 |
Why?
| | Central Nervous System | 10 | 2022 | 230 | 1.840 |
Why?
| | Hypothalamo-Hypophyseal System | 12 | 2019 | 164 | 1.830 |
Why?
| | Mental Health | 6 | 2023 | 559 | 1.780 |
Why?
| | Anxiety Disorders | 11 | 2021 | 304 | 1.770 |
Why?
| | Brain | 27 | 2022 | 2355 | 1.720 |
Why?
| | Rats, Sprague-Dawley | 31 | 2022 | 2182 | 1.690 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 11 | 2022 | 72 | 1.640 |
Why?
| | Panic Disorder | 7 | 2017 | 20 | 1.560 |
Why?
| | Organic Cation Transport Proteins | 9 | 2021 | 26 | 1.490 |
Why?
| | Male | 126 | 2024 | 55396 | 1.440 |
Why?
| | Motor Activity | 12 | 2021 | 635 | 1.390 |
Why?
| | Microglia | 6 | 2023 | 198 | 1.370 |
Why?
| | Glucocorticoids | 6 | 2023 | 526 | 1.320 |
Why?
| | Bacterial Vaccines | 4 | 2018 | 61 | 1.290 |
Why?
| | Lipopolysaccharides | 6 | 2023 | 813 | 1.250 |
Why?
| | Fluoxetine | 6 | 2023 | 46 | 1.250 |
Why?
| | Analysis of Variance | 23 | 2018 | 1218 | 1.190 |
Why?
| | Citalopram | 2 | 2018 | 28 | 1.190 |
Why?
| | Social Isolation | 3 | 2013 | 51 | 1.180 |
Why?
| | Hypothalamus | 6 | 2019 | 147 | 1.180 |
Why?
| | Depressive Disorder | 3 | 2018 | 330 | 1.150 |
Why?
| | Urocortins | 10 | 2019 | 19 | 1.150 |
Why?
| | Carbolines | 9 | 2015 | 27 | 1.140 |
Why?
| | Probiotics | 2 | 2018 | 48 | 1.140 |
Why?
| | Body Temperature Regulation | 7 | 2019 | 72 | 1.120 |
Why?
| | Environment, Controlled | 3 | 2016 | 19 | 1.120 |
Why?
| | Vaccines, Inactivated | 3 | 2018 | 68 | 1.120 |
Why?
| | Neural Pathways | 12 | 2020 | 260 | 1.110 |
Why?
| | Tryptophan | 8 | 2022 | 136 | 1.090 |
Why?
| | Disease Models, Animal | 20 | 2023 | 3498 | 1.090 |
Why?
| | Salamandridae | 11 | 2009 | 26 | 1.080 |
Why?
| | Mood Disorders | 3 | 2013 | 112 | 1.060 |
Why?
| | Depression | 10 | 2023 | 1133 | 1.060 |
Why?
| | Immunomodulation | 3 | 2016 | 84 | 1.040 |
Why?
| | Dysbiosis | 2 | 2018 | 145 | 1.040 |
Why?
| | Immunohistochemistry | 20 | 2019 | 1624 | 1.010 |
Why?
| | Cell Count | 14 | 2015 | 303 | 1.000 |
Why?
| | Anti-Anxiety Agents | 5 | 2023 | 43 | 0.990 |
Why?
| | Serotonin Receptor Agonists | 5 | 2017 | 27 | 0.990 |
Why?
| | Hippocampus | 8 | 2022 | 690 | 0.980 |
Why?
| | RNA, Messenger | 9 | 2020 | 2550 | 0.960 |
Why?
| | Panic | 4 | 2017 | 10 | 0.940 |
Why?
| | Stress, Physiological | 11 | 2014 | 379 | 0.920 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 4 | 0.890 |
Why?
| | Arousal | 6 | 2023 | 152 | 0.870 |
Why?
| | Veterans | 7 | 2024 | 1248 | 0.850 |
Why?
| | Receptor, Serotonin, 5-HT1A | 8 | 2019 | 39 | 0.850 |
Why?
| | Septal Nuclei | 3 | 2019 | 16 | 0.840 |
Why?
| | Brain Injuries, Traumatic | 4 | 2020 | 297 | 0.840 |
Why?
| | Maternal Deprivation | 4 | 2019 | 15 | 0.830 |
Why?
| | Mental Disorders | 8 | 2022 | 889 | 0.830 |
Why?
| | Caffeine | 5 | 2018 | 56 | 0.820 |
Why?
| | Inflammation Mediators | 3 | 2018 | 475 | 0.820 |
Why?
| | Reflex, Startle | 4 | 2019 | 57 | 0.810 |
Why?
| | Social Behavior | 7 | 2022 | 267 | 0.800 |
Why?
| | Hot Temperature | 3 | 2022 | 301 | 0.800 |
Why?
| | Neurons, Afferent | 4 | 2012 | 85 | 0.790 |
Why?
| | RNA, Ribosomal, 16S | 10 | 2022 | 485 | 0.790 |
Why?
| | Prefrontal Cortex | 3 | 2018 | 263 | 0.790 |
Why?
| | Carbon Dioxide | 4 | 2010 | 218 | 0.790 |
Why?
| | Immunization | 9 | 2022 | 397 | 0.770 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 180 | 0.760 |
Why?
| | Feces | 5 | 2023 | 372 | 0.760 |
Why?
| | Hydroxyindoleacetic Acid | 11 | 2018 | 19 | 0.760 |
Why?
| | Veterans Health | 2 | 2024 | 166 | 0.750 |
Why?
| | Colitis | 4 | 2019 | 223 | 0.720 |
Why?
| | Mice | 32 | 2023 | 14841 | 0.700 |
Why?
| | Exploratory Behavior | 5 | 2021 | 82 | 0.690 |
Why?
| | Mice, Inbred BALB C | 12 | 2023 | 1144 | 0.690 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 10 | 0.680 |
Why?
| | Humans | 83 | 2024 | 114043 | 0.680 |
Why?
| | Emotions | 5 | 2023 | 474 | 0.670 |
Why?
| | Environment Design | 2 | 2016 | 24 | 0.660 |
Why?
| | Toxoplasmosis | 4 | 2024 | 31 | 0.660 |
Why?
| | Body Temperature | 4 | 2018 | 208 | 0.650 |
Why?
| | Synaptic Transmission | 4 | 2018 | 227 | 0.640 |
Why?
| | Locomotion | 6 | 2021 | 81 | 0.640 |
Why?
| | Interleukin-4 | 1 | 2020 | 204 | 0.640 |
Why?
| | Serotonin Agents | 4 | 2015 | 8 | 0.630 |
Why?
| | Dominance-Subordination | 2 | 2011 | 15 | 0.620 |
Why?
| | Physical Conditioning, Animal | 2 | 2019 | 194 | 0.600 |
Why?
| | Genes, fos | 2 | 2010 | 33 | 0.590 |
Why?
| | Blood Proteins | 1 | 2020 | 222 | 0.590 |
Why?
| | Gene Expression Regulation | 9 | 2018 | 2321 | 0.590 |
Why?
| | Catecholamines | 3 | 2005 | 94 | 0.590 |
Why?
| | Housing, Animal | 2 | 2016 | 43 | 0.590 |
Why?
| | Behavior | 1 | 2018 | 91 | 0.580 |
Why?
| | Circadian Rhythm | 4 | 2021 | 356 | 0.580 |
Why?
| | Swimming | 3 | 2021 | 44 | 0.570 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 9 | 0.570 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 169 | 0.570 |
Why?
| | Hypothermia | 1 | 2017 | 37 | 0.560 |
Why?
| | Vaccination | 3 | 2020 | 1202 | 0.560 |
Why?
| | Military Personnel | 3 | 2019 | 521 | 0.560 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 801 | 0.560 |
Why?
| | Hypercapnia | 4 | 2012 | 50 | 0.550 |
Why?
| | Lipid Metabolism | 1 | 2020 | 441 | 0.550 |
Why?
| | Psychological Trauma | 1 | 2017 | 54 | 0.540 |
Why?
| | Toxoplasma | 3 | 2024 | 31 | 0.530 |
Why?
| | Social Determinants of Health | 1 | 2018 | 136 | 0.530 |
Why?
| | Parvalbumins | 2 | 2020 | 17 | 0.530 |
Why?
| | Immune System | 2 | 2014 | 171 | 0.520 |
Why?
| | Brain Concussion | 2 | 2020 | 477 | 0.520 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 4 | 0.480 |
Why?
| | Vasotocin | 4 | 2000 | 5 | 0.480 |
Why?
| | Gene Expression | 7 | 2020 | 1417 | 0.470 |
Why?
| | Post-Concussion Syndrome | 1 | 2017 | 154 | 0.460 |
Why?
| | Hormone Replacement Therapy | 1 | 2015 | 76 | 0.460 |
Why?
| | Proteomics | 1 | 2020 | 815 | 0.450 |
Why?
| | Cytokines | 7 | 2023 | 1824 | 0.450 |
Why?
| | Conditioning, Classical | 5 | 2020 | 87 | 0.450 |
Why?
| | Immobility Response, Tonic | 1 | 2013 | 4 | 0.440 |
Why?
| | Intestines | 2 | 2014 | 325 | 0.430 |
Why?
| | Interleukin-6 | 4 | 2023 | 673 | 0.430 |
Why?
| | Sex Characteristics | 2 | 2013 | 636 | 0.430 |
Why?
| | Public Health | 2 | 2022 | 433 | 0.430 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2016 | 337 | 0.430 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 545 | 0.430 |
Why?
| | Mesencephalon | 2 | 2010 | 57 | 0.420 |
Why?
| | Pons | 2 | 2010 | 30 | 0.420 |
Why?
| | Mice, Inbred C57BL | 12 | 2022 | 4680 | 0.420 |
Why?
| | Life Style | 2 | 2014 | 428 | 0.420 |
Why?
| | Cold Temperature | 1 | 2013 | 125 | 0.410 |
Why?
| | GABA Antagonists | 6 | 2013 | 32 | 0.410 |
Why?
| | Time Factors | 12 | 2015 | 6077 | 0.400 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2017 | 144 | 0.390 |
Why?
| | GABAergic Neurons | 1 | 2012 | 21 | 0.390 |
Why?
| | Prosencephalon | 6 | 2018 | 45 | 0.390 |
Why?
| | Cushing Syndrome | 1 | 2011 | 10 | 0.380 |
Why?
| | Kynurenine | 5 | 2018 | 81 | 0.380 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2015 | 1836 | 0.380 |
Why?
| | Breast Neoplasms | 1 | 2022 | 1846 | 0.380 |
Why?
| | Socioeconomic Factors | 2 | 2014 | 1080 | 0.370 |
Why?
| | Rats, Long-Evans | 6 | 2021 | 98 | 0.370 |
Why?
| | Porphyromonas gingivalis | 2 | 2022 | 17 | 0.370 |
Why?
| | Suicide | 4 | 2020 | 507 | 0.370 |
Why?
| | Brain Mapping | 5 | 2007 | 521 | 0.360 |
Why?
| | Bronchi | 1 | 2012 | 223 | 0.360 |
Why?
| | Female | 35 | 2024 | 59325 | 0.350 |
Why?
| | Light | 3 | 2008 | 336 | 0.350 |
Why?
| | Third Ventricle | 1 | 2010 | 14 | 0.350 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 144 | 0.340 |
Why?
| | Suicide, Attempted | 3 | 2019 | 316 | 0.340 |
Why?
| | Animals, Newborn | 5 | 2018 | 777 | 0.340 |
Why?
| | Cognition | 4 | 2022 | 990 | 0.330 |
Why?
| | Interneurons | 1 | 2010 | 96 | 0.330 |
Why?
| | Fenfluramine | 1 | 2009 | 13 | 0.330 |
Why?
| | Prebiotics | 2 | 2021 | 23 | 0.330 |
Why?
| | Amish | 2 | 2019 | 7 | 0.310 |
Why?
| | TRPV Cation Channels | 1 | 2008 | 30 | 0.310 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2018 | 465 | 0.310 |
Why?
| | Pets | 2 | 2018 | 20 | 0.300 |
Why?
| | Brain Chemistry | 4 | 2007 | 114 | 0.300 |
Why?
| | Sexual Behavior, Animal | 4 | 2006 | 47 | 0.300 |
Why?
| | Medulla Oblongata | 4 | 2012 | 33 | 0.300 |
Why?
| | Schizophrenia | 3 | 2016 | 412 | 0.290 |
Why?
| | RNA, Bacterial | 2 | 2020 | 174 | 0.290 |
Why?
| | Age Factors | 7 | 2021 | 2885 | 0.290 |
Why?
| | Sleep Deprivation | 2 | 2020 | 167 | 0.290 |
Why?
| | Encephalitis | 2 | 2020 | 126 | 0.280 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 15 | 0.280 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2008 | 127 | 0.280 |
Why?
| | Relaxin | 2 | 2018 | 15 | 0.280 |
Why?
| | Neuropeptides | 3 | 2018 | 63 | 0.280 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.280 |
Why?
| | Vaccines | 1 | 2012 | 375 | 0.280 |
Why?
| | Allosteric Site | 1 | 2007 | 16 | 0.280 |
Why?
| | Rats, Inbred F344 | 4 | 2019 | 241 | 0.280 |
Why?
| | Limbic System | 1 | 2007 | 43 | 0.280 |
Why?
| | Aging | 4 | 2022 | 1611 | 0.270 |
Why?
| | Maze Learning | 6 | 2021 | 87 | 0.270 |
Why?
| | Restraint, Physical | 4 | 2015 | 67 | 0.260 |
Why?
| | Receptors, GABA-A | 1 | 2007 | 82 | 0.260 |
Why?
| | Histamine | 2 | 2006 | 56 | 0.260 |
Why?
| | Up-Regulation | 4 | 2012 | 802 | 0.260 |
Why?
| | Indomethacin | 1 | 2006 | 70 | 0.260 |
Why?
| | 5-Hydroxytryptophan | 5 | 2022 | 22 | 0.260 |
Why?
| | Benzodiazepines | 1 | 2007 | 114 | 0.260 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 72 | 0.260 |
Why?
| | Receptors, Serotonin, 5-HT3 | 1 | 2005 | 15 | 0.260 |
Why?
| | Biguanides | 1 | 2005 | 12 | 0.260 |
Why?
| | Telemetry | 2 | 2017 | 36 | 0.250 |
Why?
| | In Situ Hybridization | 5 | 2012 | 292 | 0.250 |
Why?
| | Hypothalamic Area, Lateral | 1 | 2005 | 2 | 0.250 |
Why?
| | Prolactin | 2 | 2005 | 96 | 0.250 |
Why?
| | Bacteria | 3 | 2020 | 725 | 0.250 |
Why?
| | Antibodies, Protozoan | 3 | 2024 | 30 | 0.250 |
Why?
| | Environmental Microbiology | 2 | 2019 | 43 | 0.250 |
Why?
| | Vimentin | 1 | 2005 | 58 | 0.240 |
Why?
| | Life Change Events | 1 | 2005 | 135 | 0.230 |
Why?
| | Adrenal Medulla | 1 | 2004 | 7 | 0.230 |
Why?
| | Macrophages | 2 | 2023 | 1259 | 0.230 |
Why?
| | Dopamine | 3 | 2018 | 235 | 0.230 |
Why?
| | Fibroblast Growth Factor 8 | 2 | 2014 | 27 | 0.230 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 10 | 0.230 |
Why?
| | Helicobacter Infections | 2 | 2021 | 25 | 0.220 |
Why?
| | Cerebral Cortex | 1 | 2007 | 380 | 0.220 |
Why?
| | Neuroimmunomodulation | 2 | 2019 | 69 | 0.220 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2018 | 23 | 0.220 |
Why?
| | Tuberculosis, Bovine | 1 | 2023 | 3 | 0.220 |
Why?
| | Mice, Inbred Strains | 2 | 2023 | 398 | 0.220 |
Why?
| | Diazepam | 1 | 2023 | 26 | 0.220 |
Why?
| | Suicidal Ideation | 2 | 2019 | 402 | 0.220 |
Why?
| | Immunoglobulin G | 4 | 2024 | 766 | 0.210 |
Why?
| | Adult | 18 | 2022 | 30375 | 0.210 |
Why?
| | Friends | 1 | 2023 | 46 | 0.200 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 206 | 0.200 |
Why?
| | Mucins | 1 | 2022 | 61 | 0.200 |
Why?
| | Receptors, Neuropeptide | 2 | 2012 | 11 | 0.200 |
Why?
| | Random Allocation | 4 | 2009 | 328 | 0.200 |
Why?
| | Coinfection | 1 | 2023 | 120 | 0.200 |
Why?
| | Planets | 1 | 2021 | 1 | 0.190 |
Why?
| | Hydrazines | 3 | 2018 | 27 | 0.190 |
Why?
| | Norepinephrine | 5 | 2005 | 201 | 0.190 |
Why?
| | Serotonin Antagonists | 2 | 2015 | 30 | 0.190 |
Why?
| | Diet, High-Fat | 2 | 2022 | 225 | 0.190 |
Why?
| | Neopterin | 2 | 2022 | 9 | 0.190 |
Why?
| | Piperazines | 3 | 2010 | 310 | 0.190 |
Why?
| | Helicobacter pylori | 1 | 2021 | 30 | 0.190 |
Why?
| | Frailty | 1 | 2024 | 113 | 0.190 |
Why?
| | Hygiene | 2 | 2014 | 25 | 0.190 |
Why?
| | Populus | 1 | 2021 | 9 | 0.190 |
Why?
| | Adrenalectomy | 2 | 2015 | 59 | 0.180 |
Why?
| | Cholera Toxin | 3 | 2013 | 27 | 0.180 |
Why?
| | Carrier Proteins | 1 | 2005 | 694 | 0.180 |
Why?
| | Groundwater | 1 | 2021 | 32 | 0.180 |
Why?
| | Brain Stem | 3 | 2006 | 94 | 0.180 |
Why?
| | Microdialysis | 5 | 2019 | 49 | 0.180 |
Why?
| | Escape Reaction | 2 | 2017 | 58 | 0.180 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 9 | 0.180 |
Why?
| | Multiple Trauma | 1 | 2021 | 87 | 0.180 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1003 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2012 | 186 | 0.170 |
Why?
| | Epinephrine | 2 | 2005 | 163 | 0.170 |
Why?
| | Mycobacterium tuberculosis | 1 | 2023 | 269 | 0.170 |
Why?
| | United States | 6 | 2024 | 12137 | 0.170 |
Why?
| | Bile Acids and Salts | 1 | 2021 | 171 | 0.170 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 30 | 0.170 |
Why?
| | Communicable Diseases | 1 | 2022 | 127 | 0.170 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.170 |
Why?
| | DNA, Bacterial | 2 | 2020 | 312 | 0.170 |
Why?
| | Neuropsychiatry | 1 | 2020 | 15 | 0.170 |
Why?
| | Shock | 1 | 2021 | 83 | 0.170 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 53 | 0.170 |
Why?
| | Autoradiography | 2 | 2009 | 69 | 0.170 |
Why?
| | Middle Aged | 10 | 2020 | 26605 | 0.170 |
Why?
| | Periodontitis | 1 | 2020 | 41 | 0.170 |
Why?
| | United States Department of Veterans Affairs | 2 | 2024 | 561 | 0.160 |
Why?
| | Individuality | 2 | 2019 | 146 | 0.160 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2019 | 5 | 0.160 |
Why?
| | Psycholinguistics | 1 | 2019 | 19 | 0.160 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 77 | 0.160 |
Why?
| | Phobic Disorders | 1 | 2019 | 25 | 0.160 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 37 | 0.160 |
Why?
| | Mice, Knockout | 4 | 2019 | 2562 | 0.160 |
Why?
| | Memory, Episodic | 1 | 2019 | 38 | 0.160 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 9 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 328 | 0.150 |
Why?
| | Autism Spectrum Disorder | 2 | 2020 | 322 | 0.150 |
Why?
| | Biomarkers | 3 | 2024 | 3397 | 0.150 |
Why?
| | MicroRNAs | 2 | 2014 | 600 | 0.150 |
Why?
| | Hypothalamus, Middle | 2 | 2010 | 2 | 0.150 |
Why?
| | Alarmins | 1 | 2018 | 24 | 0.150 |
Why?
| | Adiponectin | 1 | 2020 | 213 | 0.150 |
Why?
| | Yohimbine | 2 | 2010 | 9 | 0.150 |
Why?
| | Housing | 1 | 2019 | 114 | 0.150 |
Why?
| | Nervous System | 1 | 1998 | 63 | 0.150 |
Why?
| | HMGB1 Protein | 1 | 2018 | 47 | 0.150 |
Why?
| | Nesting Behavior | 1 | 2018 | 15 | 0.150 |
Why?
| | Biogenic Monoamines | 2 | 2009 | 13 | 0.150 |
Why?
| | Vasopressins | 1 | 1998 | 56 | 0.150 |
Why?
| | Phenylalanine | 1 | 2018 | 57 | 0.150 |
Why?
| | Vertebrates | 1 | 1998 | 55 | 0.150 |
Why?
| | Grooming | 2 | 2009 | 4 | 0.150 |
Why?
| | Injections, Intraventricular | 2 | 2009 | 71 | 0.150 |
Why?
| | Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.150 |
Why?
| | Amphibians | 1 | 1998 | 47 | 0.140 |
Why?
| | Food Chain | 1 | 2017 | 34 | 0.140 |
Why?
| | Desipramine | 2 | 2015 | 9 | 0.140 |
Why?
| | Receptors, Glucocorticoid | 2 | 2017 | 130 | 0.140 |
Why?
| | Genetic Fitness | 1 | 2018 | 53 | 0.140 |
Why?
| | Songbirds | 1 | 2018 | 34 | 0.140 |
Why?
| | Noise | 1 | 2018 | 66 | 0.140 |
Why?
| | Tyrosine | 1 | 2018 | 210 | 0.140 |
Why?
| | Altitude | 1 | 2021 | 435 | 0.140 |
Why?
| | Impulsive Behavior | 1 | 2018 | 113 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 722 | 0.140 |
Why?
| | Helicobacter | 1 | 2016 | 5 | 0.140 |
Why?
| | Soil Microbiology | 1 | 2019 | 177 | 0.140 |
Why?
| | Hydrocortisone | 2 | 2018 | 267 | 0.140 |
Why?
| | Lipids | 1 | 2020 | 564 | 0.140 |
Why?
| | Psychomotor Performance | 1 | 2019 | 281 | 0.140 |
Why?
| | Tissue Distribution | 3 | 2006 | 285 | 0.140 |
Why?
| | Gliadin | 1 | 2016 | 12 | 0.140 |
Why?
| | Video Recording | 2 | 2009 | 141 | 0.140 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 527 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2018 | 247 | 0.130 |
Why?
| | Down-Regulation | 1 | 2018 | 594 | 0.130 |
Why?
| | Epilepsy | 1 | 2020 | 278 | 0.130 |
Why?
| | Drug Administration Routes | 2 | 2007 | 38 | 0.130 |
Why?
| | Affect | 1 | 2018 | 246 | 0.130 |
Why?
| | Species Specificity | 3 | 2023 | 541 | 0.130 |
Why?
| | Rectum | 1 | 2017 | 151 | 0.130 |
Why?
| | Biogenic Amines | 1 | 1996 | 4 | 0.130 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 4402 | 0.130 |
Why?
| | Adrenal Glands | 2 | 2016 | 66 | 0.130 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1117 | 0.130 |
Why?
| | Urban Population | 1 | 2018 | 396 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 489 | 0.120 |
Why?
| | Membrane Potentials | 1 | 1996 | 247 | 0.120 |
Why?
| | Learning | 1 | 2019 | 346 | 0.120 |
Why?
| | Radioimmunoassay | 2 | 2009 | 161 | 0.120 |
Why?
| | Staining and Labeling | 2 | 2006 | 134 | 0.120 |
Why?
| | Sleep | 4 | 2021 | 631 | 0.120 |
Why?
| | Hypoxia | 1 | 2021 | 956 | 0.120 |
Why?
| | Argonaute Proteins | 1 | 2014 | 28 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2015 | 68 | 0.120 |
Why?
| | Receptors, Steroid | 1 | 1995 | 46 | 0.120 |
Why?
| | Rural Population | 1 | 2018 | 443 | 0.120 |
Why?
| | White Matter | 1 | 2016 | 105 | 0.120 |
Why?
| | Alzheimer Disease | 1 | 2020 | 442 | 0.120 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 167 | 0.120 |
Why?
| | Chronic Disease | 2 | 2019 | 1577 | 0.120 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2014 | 45 | 0.120 |
Why?
| | Extracellular Space | 2 | 2019 | 116 | 0.120 |
Why?
| | Urbanization | 1 | 2014 | 23 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 282 | 0.110 |
Why?
| | Proteins | 1 | 2020 | 906 | 0.110 |
Why?
| | Biological Evolution | 2 | 2014 | 406 | 0.110 |
Why?
| | Oncogene Proteins v-fos | 1 | 2013 | 11 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2018 | 4392 | 0.110 |
Why?
| | Comorbidity | 2 | 2017 | 1447 | 0.110 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 48 | 0.110 |
Why?
| | Bradycardia | 2 | 2012 | 48 | 0.110 |
Why?
| | Emigration and Immigration | 1 | 2014 | 45 | 0.110 |
Why?
| | Skin | 3 | 2023 | 653 | 0.110 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2013 | 28 | 0.110 |
Why?
| | Respiration Disorders | 1 | 2014 | 68 | 0.110 |
Why?
| | Receptors, Opioid | 2 | 1990 | 19 | 0.110 |
Why?
| | Weight Gain | 2 | 2019 | 453 | 0.110 |
Why?
| | Receptors, Angiotensin | 1 | 2013 | 9 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 787 | 0.110 |
Why?
| | Rodentia | 1 | 2013 | 43 | 0.110 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2013 | 13 | 0.110 |
Why?
| | Body Weight | 1 | 2017 | 868 | 0.110 |
Why?
| | Young Adult | 5 | 2019 | 10444 | 0.100 |
Why?
| | Pilot Projects | 1 | 2017 | 1360 | 0.100 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2011 | 128 | 0.100 |
Why?
| | Amphetamine | 1 | 2012 | 22 | 0.100 |
Why?
| | Resilience, Psychological | 1 | 2014 | 95 | 0.100 |
Why?
| | Avoidance Learning | 1 | 2013 | 63 | 0.100 |
Why?
| | Angiotensin II | 1 | 2013 | 87 | 0.100 |
Why?
| | Phenotype | 3 | 2021 | 2784 | 0.100 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 3 | 0.100 |
Why?
| | Sodium Lactate | 2 | 2013 | 5 | 0.100 |
Why?
| | Brain Injuries | 1 | 2017 | 459 | 0.100 |
Why?
| | Weaning | 1 | 2012 | 48 | 0.100 |
Why?
| | Cohort Studies | 2 | 2019 | 4883 | 0.100 |
Why?
| | Memory | 3 | 2018 | 209 | 0.100 |
Why?
| | Homeostasis | 1 | 2015 | 570 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2343 | 0.100 |
Why?
| | Hypertension | 2 | 2012 | 1052 | 0.100 |
Why?
| | Electroshock | 3 | 2017 | 134 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.090 |
Why?
| | Signal Transduction | 2 | 2015 | 4501 | 0.090 |
Why?
| | Environmental Exposure | 1 | 2014 | 372 | 0.090 |
Why?
| | Sanitation | 1 | 2010 | 49 | 0.090 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 159 | 0.090 |
Why?
| | Neuronal Tract-Tracers | 1 | 2010 | 2 | 0.090 |
Why?
| | Radiography | 1 | 2013 | 803 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 182 | 0.090 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2010 | 19 | 0.090 |
Why?
| | Receptors, Adrenergic | 2 | 2006 | 35 | 0.090 |
Why?
| | Cell Lineage | 1 | 2012 | 308 | 0.090 |
Why?
| | Diet | 3 | 2023 | 1080 | 0.090 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 99 | 0.090 |
Why?
| | Feeding Behavior | 2 | 2006 | 572 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 74 | 0.080 |
Why?
| | Social Dominance | 1 | 2009 | 16 | 0.080 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2007 | 68 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 370 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 388 | 0.080 |
Why?
| | Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.080 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 926 | 0.080 |
Why?
| | Pyridines | 2 | 2013 | 419 | 0.080 |
Why?
| | Thermosensing | 1 | 2008 | 10 | 0.080 |
Why?
| | Temperature | 1 | 2011 | 564 | 0.080 |
Why?
| | Transfection | 1 | 2011 | 863 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2010 | 321 | 0.080 |
Why?
| | Mice, Transgenic | 4 | 2014 | 1947 | 0.080 |
Why?
| | Biological Transport | 2 | 2006 | 374 | 0.080 |
Why?
| | Pargyline | 1 | 2008 | 2 | 0.080 |
Why?
| | Seroepidemiologic Studies | 2 | 2019 | 137 | 0.080 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 10 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 383 | 0.080 |
Why?
| | Central Nervous System Stimulants | 2 | 2012 | 140 | 0.080 |
Why?
| | Somatoform Disorders | 1 | 2007 | 37 | 0.070 |
Why?
| | Synapses | 1 | 2010 | 331 | 0.070 |
Why?
| | Seasons | 2 | 2020 | 440 | 0.070 |
Why?
| | Aged | 3 | 2024 | 18969 | 0.070 |
Why?
| | Acoustic Stimulation | 1 | 2009 | 306 | 0.070 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2007 | 7 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2008 | 291 | 0.070 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 1981 | 0.070 |
Why?
| | Tryptamines | 1 | 2006 | 3 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 127 | 0.070 |
Why?
| | Darkness | 1 | 2006 | 23 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 662 | 0.070 |
Why?
| | Tegmentum Mesencephali | 1 | 2006 | 4 | 0.070 |
Why?
| | Tissue Fixation | 1 | 2005 | 27 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2021 | 345 | 0.060 |
Why?
| | Blood-Brain Barrier | 1 | 2006 | 106 | 0.060 |
Why?
| | Cell Membrane | 2 | 2022 | 670 | 0.060 |
Why?
| | Blood Pressure | 2 | 2013 | 1531 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2008 | 665 | 0.060 |
Why?
| | Drug Interactions | 1 | 2007 | 337 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 684 | 0.060 |
Why?
| | Median Eminence | 1 | 2005 | 4 | 0.060 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2005 | 13 | 0.060 |
Why?
| | Injections | 1 | 2005 | 160 | 0.060 |
Why?
| | Stilbamidines | 1 | 2005 | 10 | 0.060 |
Why?
| | Heart Atria | 1 | 2005 | 107 | 0.060 |
Why?
| | Autoimmunity | 1 | 2010 | 812 | 0.060 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 29 | 0.060 |
Why?
| | Perfusion | 1 | 2005 | 147 | 0.060 |
Why?
| | Microinjections | 2 | 2015 | 76 | 0.060 |
Why?
| | Nerve Fibers | 1 | 2005 | 86 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 15 | 0.060 |
Why?
| | Neurons, Efferent | 1 | 2004 | 7 | 0.060 |
Why?
| | Pregnancy | 4 | 2022 | 5499 | 0.060 |
Why?
| | Genotype | 2 | 2020 | 1757 | 0.060 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 171 | 0.060 |
Why?
| | Action Potentials | 2 | 2011 | 406 | 0.060 |
Why?
| | Blood Glucose | 2 | 2011 | 1827 | 0.050 |
Why?
| | Prednisone | 1 | 2024 | 229 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 90 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2016 | 481 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 245 | 0.050 |
Why?
| | Carbidopa | 1 | 2022 | 4 | 0.050 |
Why?
| | Orexin Receptors | 2 | 2012 | 3 | 0.050 |
Why?
| | Models, Biological | 2 | 2007 | 1611 | 0.050 |
Why?
| | Psychoneuroimmunology | 1 | 2022 | 11 | 0.050 |
Why?
| | Polysomnography | 2 | 2019 | 136 | 0.050 |
Why?
| | Exercise | 1 | 2012 | 1642 | 0.050 |
Why?
| | Receptors, Interleukin-6 | 1 | 2022 | 34 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 1143 | 0.050 |
Why?
| | Fathers | 1 | 2022 | 43 | 0.050 |
Why?
| | Bacteroidetes | 1 | 2021 | 20 | 0.050 |
Why?
| | Endophenotypes | 1 | 2021 | 16 | 0.050 |
Why?
| | Pregnancy Trimester, First | 1 | 2022 | 125 | 0.050 |
Why?
| | Anhedonia | 1 | 2021 | 9 | 0.050 |
Why?
| | Social Justice | 1 | 2022 | 67 | 0.050 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 11 | 0.050 |
Why?
| | Granulocytes | 1 | 2021 | 75 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2021 | 80 | 0.050 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 200 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2022 | 125 | 0.050 |
Why?
| | Dietary Sucrose | 1 | 2021 | 45 | 0.050 |
Why?
| | Trees | 1 | 2021 | 61 | 0.050 |
Why?
| | Rivers | 1 | 2021 | 54 | 0.050 |
Why?
| | Dreams | 1 | 2000 | 10 | 0.050 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 230 | 0.050 |
Why?
| | Choice Behavior | 1 | 2022 | 150 | 0.040 |
Why?
| | Cations | 1 | 2021 | 77 | 0.040 |
Why?
| | Microelectrodes | 1 | 2000 | 32 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 918 | 0.040 |
Why?
| | Policy | 1 | 2022 | 137 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 205 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 285 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2000 | 68 | 0.040 |
Why?
| | Benzomorphans | 2 | 1990 | 2 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 38 | 0.040 |
Why?
| | Metagenomics | 1 | 2021 | 131 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 79 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2000 | 74 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 441 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 2021 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 75 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 517 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2020 | 486 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 327 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 359 | 0.040 |
Why?
| | Normetanephrine | 1 | 2019 | 2 | 0.040 |
Why?
| | Interpersonal Relations | 2 | 2015 | 338 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2020 | 203 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 75 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2019 | 70 | 0.040 |
Why?
| | Social Environment | 2 | 2010 | 284 | 0.040 |
Why?
| | Axons | 1 | 2000 | 173 | 0.040 |
Why?
| | Reaction Time | 1 | 2000 | 373 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2024 | 470 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 410 | 0.040 |
Why?
| | Optogenetics | 1 | 2020 | 95 | 0.040 |
Why?
| | Metabolome | 1 | 2021 | 274 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 304 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 128 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 160 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 47 | 0.040 |
Why?
| | Extracellular Fluid | 2 | 2010 | 30 | 0.040 |
Why?
| | Germany | 1 | 2018 | 84 | 0.040 |
Why?
| | Agoraphobia | 1 | 2017 | 5 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 251 | 0.040 |
Why?
| | Feathers | 1 | 2018 | 34 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 8614 | 0.040 |
Why?
| | Biodiversity | 1 | 2021 | 348 | 0.040 |
Why?
| | Nucleic Acid Probes | 1 | 1997 | 1 | 0.040 |
Why?
| | Ethylmaleimide | 1 | 1997 | 18 | 0.040 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2017 | 28 | 0.040 |
Why?
| | Thionucleotides | 1 | 1997 | 34 | 0.040 |
Why?
| | Dogs | 1 | 2018 | 331 | 0.040 |
Why?
| | Body Size | 1 | 2018 | 90 | 0.040 |
Why?
| | Nerve Net | 1 | 2020 | 227 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2018 | 191 | 0.040 |
Why?
| | Picrotoxin | 1 | 2017 | 12 | 0.030 |
Why?
| | Oxytocin | 1 | 1997 | 45 | 0.030 |
Why?
| | Quinolines | 2 | 2010 | 129 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 528 | 0.030 |
Why?
| | Arizona | 1 | 2016 | 68 | 0.030 |
Why?
| | Anisotropy | 1 | 2016 | 61 | 0.030 |
Why?
| | Attention | 1 | 2019 | 394 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 695 | 0.030 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2015 | 3 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 63 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 633 | 0.030 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 13 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 434 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 296 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 5 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 380 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 733 | 0.030 |
Why?
| | Environment | 1 | 2017 | 333 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 743 | 0.030 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2014 | 22 | 0.030 |
Why?
| | Mifepristone | 1 | 2014 | 60 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1089 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 284 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 108 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2016 | 210 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4090 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2015 | 114 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2014 | 32 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 474 | 0.030 |
Why?
| | Electrochemical Techniques | 1 | 2014 | 45 | 0.030 |
Why?
| | Mothers | 1 | 1999 | 650 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 289 | 0.030 |
Why?
| | Memory Disorders | 1 | 2014 | 153 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 250 | 0.030 |
Why?
| | Receptors, Opioid, kappa | 2 | 1990 | 10 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1310 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2009 | 484 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1176 | 0.030 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 7 | 0.030 |
Why?
| | Cues | 1 | 2015 | 301 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1880 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 29 | 0.030 |
Why?
| | Odds Ratio | 1 | 2015 | 951 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1706 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2384 | 0.030 |
Why?
| | Naloxone | 2 | 1990 | 96 | 0.030 |
Why?
| | Orexins | 1 | 2012 | 4 | 0.030 |
Why?
| | Androgens | 1 | 1994 | 167 | 0.020 |
Why?
| | Naphthyridines | 1 | 2012 | 16 | 0.020 |
Why?
| | Benzoxazoles | 1 | 2012 | 16 | 0.020 |
Why?
| | Imidazoles | 1 | 2013 | 203 | 0.020 |
Why?
| | Urea | 1 | 2012 | 66 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2764 | 0.020 |
Why?
| | Fetal Development | 1 | 2014 | 248 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 314 | 0.020 |
Why?
| | Respiration | 1 | 2012 | 180 | 0.020 |
Why?
| | Muscle Strength | 1 | 2014 | 271 | 0.020 |
Why?
| | Estrogens | 1 | 1994 | 312 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 60 | 0.020 |
Why?
| | Morphinans | 1 | 1989 | 7 | 0.020 |
Why?
| | Receptors, Opioid, mu | 1 | 1990 | 52 | 0.020 |
Why?
| | Mass Screening | 1 | 2016 | 979 | 0.020 |
Why?
| | Organic Chemicals | 1 | 2010 | 112 | 0.020 |
Why?
| | Heart Rate | 1 | 2013 | 710 | 0.020 |
Why?
| | Morphine | 1 | 1990 | 121 | 0.020 |
Why?
| | Child | 2 | 2019 | 18400 | 0.020 |
Why?
| | Allylglycine | 1 | 2007 | 2 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 23 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2007 | 29 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 250 | 0.020 |
Why?
| | Pain | 1 | 2013 | 701 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 160 | 0.020 |
Why?
| | Pyrroles | 1 | 2008 | 181 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 3861 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 66 | 0.020 |
Why?
| | Obesity | 1 | 2019 | 2505 | 0.020 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 139 | 0.020 |
Why?
| | Cimetidine | 1 | 1986 | 11 | 0.020 |
Why?
| | Ranitidine | 1 | 1986 | 13 | 0.020 |
Why?
| | Growth Hormone | 1 | 1986 | 103 | 0.020 |
Why?
| | Pyrimidines | 1 | 2008 | 374 | 0.020 |
Why?
| | Testis | 1 | 1986 | 133 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 384 | 0.010 |
Why?
| | Inspiratory Capacity | 1 | 2004 | 2 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2090 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3338 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 259 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 9049 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 739 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 54 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 12521 | 0.010 |
Why?
| | Pyramidal Cells | 1 | 1999 | 51 | 0.010 |
Why?
| | Atrophy | 1 | 1999 | 152 | 0.010 |
Why?
| | Progesterone | 1 | 1999 | 232 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 207 | 0.010 |
Why?
| | RNA, Complementary | 1 | 1997 | 2 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1997 | 17 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1997 | 12 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1997 | 54 | 0.010 |
Why?
| | Estradiol | 1 | 1999 | 450 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 1957 | 0.010 |
Why?
| | Testosterone | 1 | 1994 | 341 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 4595 | 0.000 |
Why?
| | Dyspepsia | 1 | 1986 | 8 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1986 | 123 | 0.000 |
Why?
| | Glucose Tolerance Test | 1 | 1986 | 343 | 0.000 |
Why?
| | Insulin | 1 | 1986 | 2080 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|